Drugs Made In America Acquisition II Corp. (DMIIU) Non-Current Assets (2024 - 2025)
Drugs Made In America Acquisition (DMIIU) posted quarterly Non-Current Assets of $504.9 million for Q4 2025, up 643545.94% year-over-year from N/an in Q4 2024, and up 0.96% quarter-over-quarter from $500.1 million in Q3 2025.
Drugs Made In America Acquisition II Corp. (DMIIU) Non-Current Assets (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIU) has reported Non-Current Assets for 2 consecutive years, with $504.9 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Non-Current Assets rose 643545.94% year-over-year to $504.9 million; the TTM figure through Dec 2025 stood at $504.9 million (up 643545.94% YoY), while the FY2025 annual figure was $504.9 million, up 643545.94% from the prior year.
- Non-Current Assets improved to $504.9 million in Q4 2025 per DMIIU's latest filing, from $500.1 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $504.9 million in Q4 2025 and bottomed at $78449.0 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 504.93 Mn |
| Sep 30, 2025 | 500.11 Mn |
| Dec 31, 2024 | 78,449.00 |